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INTRODUCTION
The predictors of successful smoking cessation have been
investigated in many studies (1-5). Successful smoking ces-
sation was found to be associated with older age, male gen-
der, a lower consumption of cigarettes per day, owning a home,
high social status, and baseline motivation to stop smoking
(6, 7). 
Cepeda-Benito et al. reported that nicotine replacement
therapy (NRT) was efficacious for women only at short-term
(≤3 months) follow-up; however, for men, it was found to
be efficacious at all the follow up periods (≤3 months, 6
months, and ≥12 months) (8). However, to our knowledge,
there have been few studies on sociodemographic and smok-
ing behavioral predictors of smoking cessation according to
short-term (3 months), midterm (6 months), and long-term
(12 months) follow-up periods. 
In this randomized clinical trial of transdermal nicotine
patches, we examined the sociodemographic and smoking
behavioral predictors of smoking cessation according to short-
term, midterm, and long-term follow-up periods.
MATERIALS AND METHODS
Study design
This was a randomized, double-blind, placebo-controlled
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Sociodemographic and Smoking Behavioral Predictors Associated with
Smoking Cessation According to Follow-up Periods: A Randomized,
Double-blind, Placebo-controlled Trial of Transdermal Nicotine Patches
This study investigated sociodemographic and smoking behavioral factors associ-
ated with smoking cessation according to follow-up periods. In this randomized,
double-blind, placebo-controlled trial of transdermal nicotine patches, subjects were
a total of 118 adult male smokers, who were followed up for 12 months. Univariable
logistic regression analysis and stepwise multiple logistic regression analyses were
performed to identify the predictors of smoking cessation. The overall self-reported
point prevalence rates of abstinence were 20% (24/118) at 12 months follow-up,
and there was no significant difference in abstinence rates between placebo and
nicotine patch groups. In the univariable logistic regression analysis, predictors of
successful smoking cessation were the low consumption of cigarettes per day and
the low Fagerstrom Test for Nicotine Dependence (FTND) scores (p<0.05) at 3, 6,
and 12 months follow-up. In the stepwise multiple logistic regression analyses, pre-
dictors of successful smoking cessation, which were different according to the fol-
low-up periods, were found to be the low consumption of cigarettes per day at the
short-term and midterm follow-up (≤ ≤6 months), older age, and the low consump-
tion of cigarettes per day at the long-term follow-up (12 months).
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trial in which transdermal nicotine patches were used. The
study protocol, self-administered questionnaire, and consent
form were approved by the institutional review board at the
National Cancer Center.
Setting and recruitment
The subjects were all adult male office workers recruited
from the company, Kyobo Life insurance Co. We visited the
company at baseline and at all the follow-up checkups, owing
to the geographical distance between the company and the
National Cancer Center. After providing a week’s public no-
tice by means of bulletin board announcements at the com-
pany and via e-mail, we visited the company, and recruited
and enrolled the subjects only for a day on 29 July 2004. All
the subjects signed written informed consent form volun-
tarily. 
Sample size estimation
A sample size of 162 was estimated on the basis of the
results of a previous study in which the smoking abstinence
rates were approximately 40% in the nicotine patch group
and 20% in the placebo group, with a power of 80% and an
alpha level of 0.05 (9). 
Inclusion and exclusion criteria for subjects
To be eligible for this study, subjects had to be between
20 and 55 yr, in good health without any major physical or
psychiatric illness, and motivated to quit smoking regard-
less of their daily cigarette consumption. Subjects were ex-
cluded from the study if they 1) had experienced NRT within
6 months before enrollment in the study; 2) were alcohol or
narcotic drug abusers; or 3) had allergic skin diseases or
heart problems including ischemic heart disease, myocar-
dial infarction, or any type of arrhythmia or cerebrovascular
disease. 
Randomization
All the eligible subjects were randomly assigned to receive
either nicotine patches or placebo patches according to one
of two schedules provided by the computerized randomized
plan generator. We stratified the subjects by the severity of
nicotine dependence. This was done by generating two ran-
domization schedules: one for the subjects scoring 7 or more
on the Fagerstrom Test for Nicotine Dependence (FTND)
questionnaire; the other, for the subjects scoring below 7 on
the questionnaire. A score of 7 or higher was considered to
be indicative of high nicotine dependence. This entire ran-
dom allocation sequence was conducted by a third person
and remained unknown until the interventions were blindly
assigned to the two groups by the third person.
Treatment period
The total treatment period was 6 weeks. During the first
2 weeks, the subjects in the nicotine patch group wore 30 cm2
transdermal nicotine patches; during the middle 2 weeks,
they wore 20 cm2 transdermal nicotine patches; and during
the last 2 weeks, they wore 10 cm2 transdermal nicotine
patches. The subjects in the placebo patch group wore iden-
tical-appearing patches that did not contain nicotine. 
Interventions
On the first day of recruitment, all the subjects were given
either seven 30 cm2 transdermal nicotine patches with 57 mg
of nicotine in each patch, delivering 21 mg/day or seven place-
bo patches. They were instructed to apply one patch daily
and to quit smoking from the very next day after recruitment.
The nicotine patch group was given seven additional 30 cm2
nicotine patches on the 1st-week visit day; fourteen 20 cm2
transdermal nicotine patches with 38 mg of nicotine in each
patch, delivering 14 mg/day, on the 2nd-week visit day; and
fourteen 10 cm2 transdermal nicotine patches with 19 mg
of nicotine in each patch, delivering 7 mg/day, on the 4th-
week visit day. The placebo patch group was given identi-
cal-appearing patches using the same method as that used
for the nicotine patch group.
Behavioral counseling and follow-up period
We visited the company at short term (1, 2, 4, and 7 weeks
and 3 months); midterm (6 months); and long-term (12 mon-
ths) periods of follow-up after the start of the study. The sub-
jects were given one-on-one behavioral counseling for about
10 min by three doctors trained in smoking cessation thera-
py. The subjects who were absent on the appointed counsel-
ing day received telephone calls from the doctors, who pro-
vided support for smoking cessation and identified whether
or not they stopped smoking. 
Baseline assessments
At enrollment, the subjects answered a self-administered
questionnaire containing questions pertaining to sociode-
mographic characteristics and smoking behavioral factors,
and were also administered the FTND. Sociodemographic
characteristics and smoking behavioral predictors included
age, smoking initiation age, smoking duration, average daily
cigarette consumption, types of tobacco, second-hand smoke,
marriage, current diseases, alcohol drinking, exercise, educa-
tion, monthly income, and previous attempts to quit smok-
ing within the past year. The FTND questionnaire, which
consists of 6 questions and was validated in Korea, was used
to evaluate the severity of nicotine dependence (score range
was from 0 [least dependence] to 10 [highest dependence]).Blood pressure and urine cotinine concentrations were mea-
sured at baseline. 
Outcome measures
The primary outcome measure was the self-reported point
prevalence rate of abstinence at 3, 6, and 12 months follow-
up. Subjects were considered to be abstinent if at the time
of the visit, they reported not having smoked during the pre-
vious week. The subjects lost to follow-up, who were both
absent at each follow-up and not able to be kept in touch
with by telephone, were considered to be smokers. The out-
come measure analysis was conducted using the intention-
to-treat analysis.
Statistical analysis
Pearson’s chi-square test for categorical variables and a two-
sample t-test for continuous variables were used to test the
baseline differences between the treatment and control groups
with regard to the sociodemographic characteristics and smok-
ing behaviors. To study the sociodemographic and smoking
behavioral factors and their association with smoking cessa-
tion, we first performed univariable logistic regression anal-
yses at the follow-up periods of 3, 6, and 12 months. We
then conducted a stepwise multiple logistic regression anal-
ysis to determine the predictors of abstinence at the respec-
tive follow-up periods. All the statistical tests were two-sided,
and p values of 0.05 or less were considered to be statistically
significant. Data analyses were performed using SPSS 12.0
K for Windows.
RESULTS
Baseline characteristics
A total of 118 subjects entered the study from July 2004
to August 2005. The baseline characteristics of the study
population in the nicotine and placebo patch groups are
described in Table 1. At baseline, there was no significant
difference between the nicotine and placebo patch groups
with regard to the sociodemographic and lifestyle variables
(p>0.05). 
Adverse events and dropouts
Adverse events were minimal in both nicotine and place-
bo patch groups. Some examples of these events were skin
reactions at the application site, headaches, insomnia, and
dream abnormalities. No serious adverse events were report-
ed in either group. No subject was dropped out; all the sub-
jects who were not present at the time of the scheduled visit
were interviewed by telephone.
Univariable logistic regression analysis
Using univariable logistic regression analysis, we identified
several sociodemographic and smoking behavioral factors
related to the status of abstinence, as a result of the smoking
cessation intervention, at different follow-up periods (Table
2). Throughout all the follow-up periods, the cigarette con-
sumption per day and the FTND scores, which revealed the
severity of nicotine dependence, showed a significant differ-
ence in the self-reported abstinence rates (p<0.05).
The overall self-reported point prevalence rates of absti-
nence were 20.3% (24/118) at 3 months follow-up, 24.6%
(29/118) at 6 months follow-up, and 20.3% (24/118) at 12
months follow-up; furthermore, the abstinence rates between
the placebo and nicotine patch groups were not significantly
different across the follow-up periods. At 12 months follow-
up, successful abstinence was significantly associated with
increasing age (OR=1.09; 95% CI, 1.01-1.18) and marginal-
ly significantly associated with increasing years of smoking
cigarettes (OR=1.08; 95% CI, 1.00-1.16). 
At 3 months and 12 months follow-up, the baseline uri-
Predictors of Smoking Cessation 1067
*, Plus-minus values are means±SD. The unit of the values in round
brackets is percentage. Percentages do not sum up to 100 due to roun-
ding. 
� , p values obtained from Pearson’s chi-square test for the cate-
gorical variables and the two-sample t-test for continuous variables.
FTND, Fagerstrom Test for Nicotine Dependence; BMI, body mass index.
Baseline 
characteristics
Placebo patch
group (n=59)
Nicotine patch
group (n=59)
p
�
Age (yr) 36.7±6.2 36.6±5.6 0.96
Age at start of smoking (yr)  20.2±2.6 19.6±2.0 0.16
Years of cigarette smoking 16.5±5.8 17.1±5.7 0.60
No. of cigarettes per day 15.3±5.1 15.0±5.8 0.80
Degree of puff 0.93
Deep 18 (30.5) 18 (30.5)
Mid 37 (62.7) 38 (64.4)
Shallow 4 (6.8) 3 (5.1)
No. of attempts to quit smoking   0.93±1.20 1.11±1.70 0.52
in the previous year
FTND scores 3.0±2.1 2.8±2.3 0.63
Marital status 0.37
Not married 11 15
Married 48 44
Monthly income ($1=1,150 won) 0.47
<$1,739 (2 million won) 11 (18.6) 11 (19.0)
$1,739-$2,608 (2-3 million won) 33 (55.9) 28 (48.3)
>$2,608 (3 million won) 15 (25.4) 19 (32.8)
Education 0.36
High school graduate 2 (3.4) 0 (0)
College graduate  50 (84.7) 51 (86.4)
Postgraduate 7 (11.9) 8 (13.6)
BMI 24.1±2.6 23.9±2.7 0.67
Frequency of alcohol drinking  2.0±1.0 2.0±1.1 0.81
per week
Frequency of exercise per week 1.5±1.7 1.5±1.4 0.95
Table 1. Baseline characteristics of the study population (n=
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Variable
Abstinence (%)
3 months 
follow-up
6 months
follow-up
12 months
follow-up
No. of
subjects
Univariable OR (95% CI)
3 months 
follow-up
6 months 
follow-up
12 months 
follow-up
Patch
Placebo 59 10 (16.9) 12 (20.3) 11 (18.6) 1 1 1
Nicotine 59 14 (23.7) 17 (28.8) 13 (22.0) 1.52 (0.62-3.78) 1.59 (0.68-3.70) 1.23 (0.50-3.03)
Age (continuous)* 1.05 (0.98-1.14) 1.04 (0.97-1.12) 1.09 (1.01-1.18)
Age at the start of smoking (yr)
≤18 29 4 (13.8) 5 (17.2) 5 (17.2) 1 1 1
≥19 89 20 (22.5) 24 (27.0) 19 (21.3) 1.81 (0.56-5.82) 1.77 (0.61-5.17) 1.30 (0.44-3.87)
Years of cigarette smoking  1.05 (0.97-1.13) 1.04 (0.96-1.11) 1.08 (1.00-1.16)
(continuous)
�
Cigarettes per day*
≤10 37 14 (37.8) 16 (43.2) 14 (37.8) 1 1 1
11-15 32 5 (15.6) 6 (18.8) 4 (12.5) 0.30 (0.10-0.97) 0.30 (0.10-0.91) 0.24 (0.07-0.81)
≥16 49 5 (10.2) 7 (14.3) 6 (12.2) 0.19 (0.06-0.58) 0.22 (0.08-0.61) 0.23 (0.08-0.68)
Degree of puff
Deep 36 7 (19.4) 6 (16.7) 6 (16.7) 1 1 1
Mid 75 15 (20.0) 21 (28.0) 15 (20.0) 1.04 (0.38-2.82) 1.94 (0.71-5.35) 1.25 (0.44-3.55)
Shallow 7 2 (28.6) 2 (28.6) 3 (42.9) 1.66 (0.26-10.39) 2.00 (0.31-12.84) 3.75 (0.66-21.25)
Frequency of attempts to quit smoking in the previous year
0 56 11 (19.6) 13 (23.2) 12 (21.4) 1 1 1
1-2 46 10 (21.7) 14 (30.4) 9 (19.6) 1.14 (0.43-2.97) 1.45 (0.60-3.50) 0.89 (0.34-2.35)
>3 16 3 (18.8) 2 (12.5) 3 (18.8) 0.94 (0.23-3.90) 0.47 (0.10-2.36) 0.85 (0.21-3.46)
FTND score (continuous)* 0.74 (0.58-0.95) 0.68 (0.54-0.87) 0.74 (0.58-0.95)
Marital status
Not married 26 5 (19.2) 6 (23.1) 3 (11.5) 1 1 1
Married 92 19 (20.7) 23 (25.0) 21 (22.8) 1.09 (0.37-3.28) 1.11 (0.40-3.10) 2.27 (0.62-8.30)
Monthly income ($1=1,150 won) 
< $1,739 (2 million won) 22 2 (9.1) 5 (22.7) 3 (13.6) 1 1 1
$1,739-$2,608 (2-3 million won) 61 12 (19.7) 14 (23.0) 11 (18.0) 2.45 (0.50-11.95) 1.01 (0.32-3.24) 1.39 (0.39-5.54)
>$2,608 (3 million won) 34 9 (26.5) 9 (26.5) 9 (26.5) 3.60 (0.70-18.58) 1.22 (0.35-4.29) 2.28 (0.54-9.58)
Education
High school graduate 2 1 (50.0) 1 (50.0) 1 (50.0) 1 1 1
College graduate 101 21 (20.8) 26 (25.7) 22 (21.8) 0.26 (0.02-4.37) 0.35 (0.02-5.74) 0.28 (0.02-4.63)
Postgraduate 15 2 (13.3) 2 (13.3) 1 (6.7) 0.15 (0.01-3.58) 0.15 (0.01-3.58) 0.07 (0.002-2.22)
BMI
<23 38 6 (15.8) 8 (21.1) 6 (15.8) 1 1 1
≥23 79 18 (22.8) 21 (26.6) 18 (22.8) 1.57 (0.57-4.36) 1.36 (0.54-3.43) 1.57 (0.57-4.36)
Frequency of alcohol drinking per week
<1 14 5 (35.7) 5 (35.7) 5 (35.7) 1 1 1
1-2 60 9 (15.0) 13 (21.7) 8 (13.3) 0.32 (0.09-1.17) 0.50 (0.14-0.75) 0.28 (0.07-1.04)
>2 44 10 (20.3) 11 (25.0) 11 (25.0) 0.53 (0.14-1.94) 0.60 (0.17-2.18) 0.60 (0.17-2.18)
Frequency of exercise per week
Never 27 4 (14.8) 4 (14.8) 6 (22.2) 1 1 1
≤1 48 9 (18.8) 13 (27.1) 9 (18.8) 1.33 (0.37-4.80) 2.14 (0.62-7.37) 0.81 (0.25-2.58)
>1 37 11 (29.7) 11 (29.7) 9 (24.3) 2.43 (0.68-8.70) 2.43 (0.68-8.70) 1.13 (0.35-3.65)
Urinary cotinine (ng/mL)*
≤500 33 13 (39.4) 13 (39.4) 13 (39.4) 1 1 1
501-1,000 29 4 (13.8) 6 (20.7) 4 (13.8) 0.25 (0.07-0.87) 0.40 (0.13-1.25) 0.25 (0.07-0.87)
1,001-1,500 25 4 (16.0) 4 (16.0) 4 (16.0) 0.29 (0.08-1.05) 0.29 (0.08-1.05) 0.29 (0.08-1.05)
≥1,501 20 2 (10.0) 3 (15.0) 2 (10.0) 0.17 (0.03-0.86) 0.27 (0.07-1.11) 0.17 (0.03-0.86)
Table 2. Univariable logistic regression analysis of sociodemographic and smoking behavioral factors related to the status of absti-
nence at different follow-up periods (n=118)
*, Significant (p<0.05) at 12 months follow-up. 
� , Marginally significant at 12 months follow-up.
The unit of the values in the round brackets is percentage. Percentages do not add up to 100 due to rounding.
OR, odds ratio; CI, confidence interval; FTND, Fagerstrom Test for Nicotine Dependence; BMI, body mass index. Predictors of Smoking Cessation 1069
nary cotinine concentration was also inversely associated with
the abstinence rate.
However, age at the start of smoking, degree of puff, fre-
quency of attempts to quit smoking in the previous year,
marital status, monthly income, education, body mass index
(BMI), frequency of alcohol drinking per week, and frequen-
cy of exercise per week were not shown to be significantly
associated with the smoking abstinence rate. 
Stepwise multiple logistic regression analysis
To identify the adjusted predictors of abstinence according
to the follow-up periods, we conducted a multiple logistic
regression analysis with forward stepwise selection and with
an entry criteria of 0.10 and an elimination criteria of 0.10.
Age was included in the final model and ‘years of smoking
cigarettes’ was excluded because of its collinearity with age.
Moreover, considering the multicollinearity among number
of cigarettes per day, FTND score, and baseline urinary coti-
nine concentration, only the variable of number of cigarettes
per day, which showed the strongest association with absti-
nence rate, was included in the final model.
The final multivariable model showed that only the vari-
able of number of cigarettes per day was the predictor of
smoking cessation at short-term and midterm follow-up;
however, the variables of age and cigarettes per day were the
predictors of smoking cessation at long-term follow-up. The
main outcomes of the final model at long-term follow-up
were as follows: a higher success rate in the older subjects
(adjusted OR=1.10; 95% CI, 1.01-1.20) as well as a lower
consumption of cigarettes per day (adjusted OR of 11-15
cigarettes per day compared with ≤10 cigarettes per day=
0.24; 95% CI, 0.07-0.91 and for ≥16, adjusted OR=0.19;
95% CI, 0.06-0.63) (Table 3).
DISCUSSION
Several studies have shown that the main predictors of
smoking cessation are age, gender, the daily consumption of
tobacco, housing conditions, social status, baseline motiva-
tion to stop smoking, and so on (1, 6, 7).
In the present study, we found that only the number of ciga-
rettes per day was a significant predictor for smoking cessa-
tion at short-term (3 months) and midterm (6 months) fol-
low-up; however, at long-term (12 months) follow-up, age
and number of cigarettes per day were the predictors of suc-
cessful smoking cessation. 
We do not have a clear answer to why age was found to
be a predictor of long-term smoking cessation. However, we
can infer that although younger smokers succeeded in quit-
ting smoking at the short-term and midterm follow-up pe-
riod after the onset of the therapy, compared to older smok-
ers, they were relatively more prone to failing to maintain
their smoking cessation; this could be due to less motivation
or the thought of other opportunities for smoking cessation
in the future. In addition, generally, older subjects tended
to maintain smoking cessation better than the younger ones
(2-4); this is thought to be associated with the fact that older
subjects are more likely to be confronted with health deterio-
ration and accompanying medical advice to quit smoking
(1, 2). Among those who did recognize the dangers, there
was greater motivation to quit smoking and a greater suc-
cess rate; for example, among the older subjects, the former
smokers believed that smoking definitely increases the chance
of developing heart disease to a greater extent than the cur-
rent smokers (10, 11). 
It has been well known that smokers who smoke few ciga-
rettes per day are more likely to quit and maintain the ab-
stinence than smokers who smoke a large number of cigarettes
per day (6, 7, 12). A high consumption of cigarettes per day
is associated with high nicotine dependence and a low smok-
ing cessation rate (12-14). In the univariable analysis of our
study, the consumption of cigarettes per day, the FTND score,
and urinary cotinine concentration were found to be signifi-
cant predictors of smoking cessation. The correlation coeffi-
cients between the consumption of cigarettes per day and
the FTND score, between the consumption of cigarettes per
day and urinary cotinine concentration, and between the
FTND score and urinary cotinine concentration were 0.65,
0.61, and 0.57, respectively, and were all statistically signif-
icant. These results were compatible with those of the pre-
vious study (15). In the final model, we included only the
*Odds ratio adjusted for age, age at start of smoking, No. of cigarettes
per day, degree of puff, No. of attempts to quit smoking in the previous
year, marital status, monthly income, education, body mass index, fre-
quency of alcohol drinking per week, and frequency of exercise per
week. 
Variable Adjusted  OR* 95%  CI
Short-term follow-up
No. of cigarettes per day
≤10 1
11-15 0.39 0.12-1.26
≥16 0.22 0.07-0.68
Midterm follow-up
No. of cigarettes per day
≤10 1
11-15 0.38 0.13-1.17
≥16 0.21 0.07-0.62
Long-term follow-up
Age (continuous)  1.10 1.01-1.20
No. of cigarettes per day
≤10 1
11-15 0.24 0.07-0.91
≥16 0.19 0.05-0.63
Table 3. Significant predictors of successful smoking cessation
in multiple logistic regression models with forward stepwise selec-
tion at short-term (3 months), midterm (6 months), and long-
term (12 months) follow-upconsumption of cigarettes per day, which was the strongest
contributing factor as a predictor of successful smoking ces-
sation in order to avoid the multicollinearity among the vari-
ables. 
One interesting finding in the present study was that the
point prevalence rate of abstinence was the highest at 6 mon-
ths follow-up, although generally, the abstinence rate tends
to decrease with the passage of time. However, our finding
was thought to be associated with the subjects’ New Year’s
resolutions to quit smoking. The 6-month follow-up fell on
a day in February 2005, when many smokers in Korea were
motivated to try to quit smoking; therefore, the abstinence
rate at 6 months follow-up was believed to have increased
conversely as compared with the abstinence rate at 3 months
follow-up. Contrary to the point prevalence abstinence rates,
the continuous abstinence rates decreased linearly as follows:
20.3% at 3 months follow-up, 17.8% at 6 months follow-
up, and 15.3% at 12 months follow up (data not shown). 
The main limitations of our study were as follows: 1) we
could not present the continuous abstinence rate validated
with an expired CO concentration or urinary cotinine con-
centration, owing to the non-compliance of the subjects at
the follow-up periods; only 9 among 24 subjects, who re-
ported abstinence at 12 months follow up, took the urinary
cotinine examination; 2) the inclusion of only males in a
localized workplace reduced the generalizability of these find-
ings; and 3) we could not confirm that the difference between
the direct visit counseling and the telephone interview would
influence the abstinence rate.
In conclusion, this study was the first randomized, double-
blind, placebo-controlled trial of nicotine patch to show that
sociodemographic and smoking behavior factors associated
with successful smoking cessation were different according
to the follow-up periods. The results of this study can aid
physicians to clinically help smokers to quit smoking in smok-
ing cessation units. In the future, further studies on larger
populations including women will be needed to investigate
more predictors for successful smoking cessation.
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